 "RPG Life Sciences gains on getting EUGMP certification for formulation facility at Ankleshwar")
RPG Life Sciences has rallied 11% to Rs 260 on the BSE in early morning trade after the pharmaceutical company announced that it has received GMP Certificate from Bavarian Authority, a competent authority in Germany.
“The company has received GMP Certificate from Bavarian Authority, a competent authority in Germany, as per EUGMP standards for its formulation manufacturing facility at 3102/A, G.l.D.C. Industrial Estate, Ankleshwar, District Bharuch, Gujarat,” RPG Life Sciences said in a press release.
Bavarian Authority had conducted audit of the manufacturing facility in early March 2016.
“This is a major milestone for us. The certification will help in boosting sales by expanding the company's geographical presence in the European markets. It also reinforces the quality systems established by the company in line with the current stringent good manufacturing practices,” commented CT. Renganathan, Managing Director, RPG Life Sciences.
At 09:23 AM, the stock was up 6% at Rs 248 on the BSE. A combined 115,764 shares changed hands on the counter on the BSE and NSE so far.
“The company has received GMP Certificate from Bavarian Authority, a competent authority in Germany, as per EUGMP standards for its formulation manufacturing facility at 3102/A, G.l.D.C. Industrial Estate, Ankleshwar, District Bharuch, Gujarat,” RPG Life Sciences said in a press release.
Bavarian Authority had conducted audit of the manufacturing facility in early March 2016.
“This is a major milestone for us. The certification will help in boosting sales by expanding the company's geographical presence in the European markets. It also reinforces the quality systems established by the company in line with the current stringent good manufacturing practices,” commented CT. Renganathan, Managing Director, RPG Life Sciences.
At 09:23 AM, the stock was up 6% at Rs 248 on the BSE. A combined 115,764 shares changed hands on the counter on the BSE and NSE so far.
